Publication | Open Access

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

UrologySerum MesothelinMedicineUrinary MesothelinGynecologyGreater SensitivityOncologyCancer ResearchEndocrine-related CancerOvarian Cancer